ACADIA Pharmaceuticals Inc. (ACAD)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
As of 02:28PM EDT. Market open.
| Previous Close | 17.05 |
| Open | 17.15 |
| Bid | 17.19 x 100 |
| Ask | 17.24 x 100 |
| Day's Range | 17.06 - 17.42 |
| 52 Week Range | 16.16 - 33.99 |
| Volume | |
| Avg. Volume | 1,820,233 |
| Market Cap | 2.846B |
| Beta (5Y Monthly) | 0.39 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- Zacks
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Let us look at five drug, generic companies, PRGO, IOVA, VTRS, TEVA and ACAD, which are gearing up for their earnings release this week.
- GuruFocus.com
Insider Sale: CEO Stephen Davis Sells Shares of ACADIA Pharmaceuticals Inc (ACAD)
On May 2, 2024, Stephen Davis, the CEO of ACADIA Pharmaceuticals Inc (NASDAQ:ACAD), sold 11,427 shares of the company.
- Simply Wall St.
ACADIA Pharmaceuticals (NASDAQ:ACAD) shareholders have endured a 37% loss from investing in the stock five years ago
In order to justify the effort of selecting individual stocks, it's worth striving to beat the returns from a market...
© 2024 Yahoo. All rights reserved.